Evidence map›Paper›PMID 30210237›Full record

ArticleOncoTargets and therapy2018

Prognostic value of

Hui Wang, Yaxing Zhou, Qian Liu, Jiarong Xu, Yuqing Ma

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in OncoTargets and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Cancer stem-like cells contribute to paclitaxel resistance in esophageal squamous cell carcinoma.International journal of clinical and experimental pathology · 2022
    Article
  6. Article
  7. Article
  8. TNNC1 Reduced Gemcitabine Sensitivity of Nonsmall-Cell Lung Cancer by Increasing Autophagy.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hui WangThe Department of Pathology, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, China, 394202231@qq.com.
Yaxing ZhouThe Department of Pathology, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, China, 394202231@qq.com.
Qian LiuThe Department of Pathology, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, China, 394202231@qq.com.
Jiarong XuThe Department of Anesthesiology, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, China.
Yuqing MaThe Department of Pathology, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, China, 394202231@qq.com.
First Affiliated Hospital of Xinjiang Medical University · CNXinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we evaluated

Indexed as

Cyclin D1esophageal squamous cell carcinomaki-67p53prognosisSOX2

Identifiers

PMID30210237
PMCPMC6114475
OpenAlexW2888770043

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.